85 related articles for article (PubMed ID: 25888271)
1. Is dexamethasone a better partner for abiraterone than prednisolone?
Dizdar O
Oncologist; 2015 May; 20(5):e13. PubMed ID: 25888271
[TBL] [Abstract][Full Text] [Related]
2. Expanding the use of abiraterone in prostate cancer: Is earlier always better?
Schmidt KT; Madan RA; Figg WD
Cancer Biol Ther; 2018 Feb; 19(2):97-100. PubMed ID: 29219670
[No Abstract] [Full Text] [Related]
3. Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.
Saad F; Shore N; Van Poppel H; Rathkopf DE; Smith MR; de Bono JS; Logothetis CJ; de Souza P; Fizazi K; Mulders PF; Mainwaring P; Hainsworth JD; Beer TM; North S; Fradet Y; Griffin TA; De Porre P; Londhe A; Kheoh T; Small EJ; Scher HI; Molina A; Ryan CJ
Eur Urol; 2015 Oct; 68(4):570-7. PubMed ID: 25985882
[TBL] [Abstract][Full Text] [Related]
4. Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer.
Petrioli R; Francini E; Fiaschi AI; Laera L; Miano ST; De Rubertis G; Roviello G
Anticancer Res; 2015 May; 35(5):3097-102. PubMed ID: 25964601
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer: PSA kinetics predict survival in patients treated with abiraterone.
Fenner A
Nat Rev Urol; 2015 May; 12(5):240. PubMed ID: 25896180
[No Abstract] [Full Text] [Related]
6. Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.
Salvi S; Casadio V; Conteduca V; Burgio SL; Menna C; Bianchi E; Rossi L; Carretta E; Masini C; Amadori D; Calistri D; Attard G; De Giorgi U
Br J Cancer; 2015 May; 112(10):1717-24. PubMed ID: 25897673
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.
Conteduca V; Caffo O; Derosa L; Veccia A; Petracci E; Chiuri VE; Santoni M; Santini D; Fratino L; Maines F; Testoni S; De Giorgi U
Prostate; 2015 Sep; 75(12):1329-38. PubMed ID: 25982919
[TBL] [Abstract][Full Text] [Related]
8. A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.
Ueda Y; Matsubara N; Takizawa I; Nishiyama T; Tabata K; Satoh T; Kamiya N; Suzuki H; Kawahara T; Uemura H
Jpn J Clin Oncol; 2015 Aug; 45(8):774-9. PubMed ID: 25981621
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics and clinical efficacy of abiraterone acetate for treating metastatic castration-resistant prostate cancer.
Han CS; Patel R; Kim IY
Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):967-75. PubMed ID: 25936418
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger.
Caffo O; Ortega C; Di Lorenzo G; Sava T; De Giorgi U; Cavaliere C; Macrini S; Spizzo G; Aieta M; Messina C; Tucci M; Lodde M; Mansueto G; Zucali PA; Alesini D; D'Angelo A; Massari F; Morelli F; Procopio G; Ratta R; Fratino L; Lo Re G; Pegoraro MC; Zustovich F; Vicario G; Ruatta F; Federico P; La Russa F; Burgio SL; Maines F; Veccia A; Galligioni E
Urol Oncol; 2015 Jun; 33(6):265.e15-21. PubMed ID: 25907622
[TBL] [Abstract][Full Text] [Related]
11. Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.
Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D
Oncotarget; 2015 May; 6(14):12520-8. PubMed ID: 25904051
[TBL] [Abstract][Full Text] [Related]
12. Enzalutamide for patients with metastatic castration-resistant prostate cancer.
Ramadan WH; Kabbara WK; Al Basiouni Al Masri HS
Onco Targets Ther; 2015; 8():871-6. PubMed ID: 25945058
[TBL] [Abstract][Full Text] [Related]
13. Long-term Efficacy and Safety Results: Can Enzalutamide Challenge the Dogma of Androgen Deprivation Therapy in Hormone-naïve Prostate Cancer?
Albiges L; Loriot Y; Massard C; Fizazi K
Eur Urol; 2015 Nov; 68(5):802-4. PubMed ID: 25922192
[No Abstract] [Full Text] [Related]
14. The development of abiraterone acetate for castration-resistant prostate cancer.
Grist E; Attard G
Urol Oncol; 2015 Jun; 33(6):289-94. PubMed ID: 26025264
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.
Small EJ; Lance RS; Gardner TA; Karsh LI; Fong L; McCoy C; DeVries T; Sheikh NA; GuhaThakurta D; Chang N; Redfern CH; Shore ND
Clin Cancer Res; 2015 Sep; 21(17):3862-9. PubMed ID: 25925891
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: PREVAILing wind blows more good news for enzalutamide.
Fenner A
Nat Rev Urol; 2015 Jun; 12(6):304. PubMed ID: 25917887
[No Abstract] [Full Text] [Related]
17. Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience.
Ishida N; Araki K; Sakai T; Kobayashi K; Kobayashi T; Fukada I; Hosoda M; Yamamoto M; Ichinokawa K; Takahashi S; Iwase T; Ito Y; Yamashita H
Breast Cancer; 2016 Jul; 23(4):617-23. PubMed ID: 25896598
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC).
Penning TM
J Steroid Biochem Mol Biol; 2015 Sep; 153():105-13. PubMed ID: 26032458
[TBL] [Abstract][Full Text] [Related]
19. Re: Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
Taneja SS
J Urol; 2015 Jun; 193(6):1983. PubMed ID: 25986794
[No Abstract] [Full Text] [Related]
20. Pharmacology: How abiraterone works.
Thoma C
Nat Rev Urol; 2015 Jul; 12(7):363. PubMed ID: 26032546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
